Gene Symbol | Gene ID | Gene Info |
---|---|---|
SOX6
|
ENSG00000110693.11 | SRY-box transcription factor 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_16302023_16302174 | SOX6 | 60717 | 0.153610 | 0.33 | 3.8e-01 | Click! |
chr11_16349162_16349313 | SOX6 | 13578 | 0.301908 | 0.20 | 6.1e-01 | Click! |
chr11_16301713_16301864 | SOX6 | 61027 | 0.152802 | 0.19 | 6.3e-01 | Click! |
chr11_16490337_16490488 | SOX6 | 7523 | 0.308262 | -0.05 | 9.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_58821066_58821723 | 0.50 |
ENSG00000252534 |
. |
5013 |
0.22 |
chr19_34359259_34359976 | 0.48 |
ENSG00000240626 |
. |
58913 |
0.13 |
chr9_18476160_18476529 | 0.46 |
ADAMTSL1 |
ADAMTS-like 1 |
2113 |
0.45 |
chr4_157890038_157890662 | 0.32 |
PDGFC |
platelet derived growth factor C |
1705 |
0.41 |
chrX_40004759_40006118 | 0.31 |
BCOR |
BCL6 corepressor |
444 |
0.9 |
chr1_172109829_172110023 | 0.30 |
ENSG00000207949 |
. |
1879 |
0.31 |
chr2_1711742_1712354 | 0.30 |
PXDN |
peroxidasin homolog (Drosophila) |
15706 |
0.26 |
chr17_38601617_38601849 | 0.30 |
IGFBP4 |
insulin-like growth factor binding protein 4 |
2020 |
0.24 |
chr9_12776574_12776837 | 0.30 |
LURAP1L |
leucine rich adaptor protein 1-like |
1685 |
0.38 |
chr9_13568681_13569117 | 0.29 |
MPDZ |
multiple PDZ domain protein |
289310 |
0.01 |
chr15_95388341_95388759 | 0.29 |
MCTP2 |
multiple C2 domains, transmembrane 2 |
489347 |
0.01 |
chr8_93115764_93116215 | 0.29 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
475 |
0.9 |
chr7_93465582_93465846 | 0.28 |
TFPI2 |
tissue factor pathway inhibitor 2 |
53768 |
0.12 |
chr3_149938739_149938966 | 0.28 |
RP11-167H9.4 |
|
123033 |
0.05 |
chr15_39876247_39876621 | 0.28 |
THBS1 |
thrombospondin 1 |
3140 |
0.25 |
chr10_74854683_74854852 | 0.28 |
P4HA1 |
prolyl 4-hydroxylase, alpha polypeptide I |
1841 |
0.21 |
chr11_131780761_131781452 | 0.28 |
NTM |
neurotrimin |
209 |
0.95 |
chr4_81195528_81195918 | 0.27 |
FGF5 |
fibroblast growth factor 5 |
7930 |
0.26 |
chr2_102051443_102051701 | 0.27 |
RFX8 |
RFX family member 8, lacking RFX DNA binding domain |
39165 |
0.16 |
chr12_118626563_118627015 | 0.27 |
TAOK3 |
TAO kinase 3 |
1538 |
0.42 |
chr17_78044749_78045392 | 0.27 |
CCDC40 |
coiled-coil domain containing 40 |
12346 |
0.15 |
chr1_164529222_164529675 | 0.27 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
388 |
0.91 |
chr11_121800761_121801203 | 0.27 |
ENSG00000252556 |
. |
74081 |
0.11 |
chr3_120149251_120149402 | 0.27 |
FSTL1 |
follistatin-like 1 |
20512 |
0.22 |
chr8_42054040_42054280 | 0.26 |
PLAT |
plasminogen activator, tissue |
944 |
0.52 |
chr2_200446222_200446758 | 0.26 |
SATB2 |
SATB homeobox 2 |
110501 |
0.07 |
chr7_39504844_39505021 | 0.26 |
POU6F2-AS1 |
POU6F2 antisense RNA 1 |
58987 |
0.12 |
chr7_41738474_41738677 | 0.26 |
INHBA |
inhibin, beta A |
1632 |
0.38 |
chr6_3324359_3324736 | 0.26 |
RP11-506K6.4 |
|
12651 |
0.23 |
chr1_150245669_150245859 | 0.26 |
C1orf54 |
chromosome 1 open reading frame 54 |
581 |
0.54 |
chr2_68953487_68953638 | 0.26 |
ARHGAP25 |
Rho GTPase activating protein 25 |
8351 |
0.26 |
chr11_124768607_124768899 | 0.26 |
ROBO4 |
roundabout, axon guidance receptor, homolog 4 (Drosophila) |
576 |
0.61 |
chr7_27218725_27218915 | 0.26 |
RP1-170O19.20 |
Uncharacterized protein |
812 |
0.27 |
chr3_49064758_49065280 | 0.26 |
IMPDH2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
887 |
0.3 |
chr4_128553582_128553997 | 0.25 |
INTU |
inturned planar cell polarity protein |
298 |
0.94 |
chr15_80696207_80696642 | 0.25 |
ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
269 |
0.71 |
chr4_171010363_171010619 | 0.25 |
AADAT |
aminoadipate aminotransferase |
54 |
0.98 |
chr5_83680091_83680703 | 0.25 |
CTD-2269F5.1 |
|
23 |
0.71 |
chr12_71003154_71004126 | 0.24 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
16 |
0.99 |
chr1_94219763_94219914 | 0.24 |
RP11-488P3.1 |
|
21162 |
0.21 |
chr7_92327766_92328157 | 0.24 |
ENSG00000206763 |
. |
3167 |
0.33 |
chr9_128288246_128288397 | 0.24 |
ENSG00000243845 |
. |
12835 |
0.21 |
chr5_113697124_113698006 | 0.24 |
KCNN2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
451 |
0.9 |
chr13_24007498_24007984 | 0.24 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
100 |
0.98 |
chr8_108344303_108344567 | 0.24 |
ANGPT1 |
angiopoietin 1 |
4315 |
0.34 |
chr15_23743478_23743629 | 0.24 |
GOLGA6L2 |
golgin A6 family-like 2 |
51172 |
0.11 |
chr1_79471738_79472138 | 0.24 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
465 |
0.9 |
chr6_111738419_111738706 | 0.24 |
REV3L-IT1 |
REV3L intronic transcript 1 (non-protein coding) |
55752 |
0.11 |
chr15_99847895_99848073 | 0.24 |
AC022819.2 |
Uncharacterized protein |
11844 |
0.18 |
chr21_46573548_46573916 | 0.23 |
ADARB1 |
adenosine deaminase, RNA-specific, B1 |
17825 |
0.17 |
chr13_24006860_24007105 | 0.23 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
859 |
0.74 |
chr7_111724737_111724893 | 0.23 |
DOCK4 |
dedicator of cytokinesis 4 |
80629 |
0.1 |
chr15_48469342_48470564 | 0.23 |
MYEF2 |
myelin expression factor 2 |
597 |
0.66 |
chr5_67714061_67714212 | 0.23 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
125740 |
0.06 |
chr18_6729547_6730123 | 0.23 |
ARHGAP28 |
Rho GTPase activating protein 28 |
14 |
0.5 |
chr10_104536012_104536214 | 0.23 |
WBP1L |
WW domain binding protein 1-like |
107 |
0.96 |
chr1_33812781_33812932 | 0.23 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
2630 |
0.17 |
chr6_7692698_7692863 | 0.23 |
BMP6 |
bone morphogenetic protein 6 |
34250 |
0.21 |
chr2_238318512_238318719 | 0.23 |
COL6A3 |
collagen, type VI, alpha 3 |
4176 |
0.24 |
chr18_74333391_74333920 | 0.23 |
LINC00908 |
long intergenic non-protein coding RNA 908 |
92781 |
0.08 |
chr10_6962147_6962542 | 0.23 |
PRKCQ |
protein kinase C, theta |
340081 |
0.01 |
chr19_18497517_18497681 | 0.22 |
ENSG00000264175 |
. |
227 |
0.74 |
chr4_124365503_124365798 | 0.22 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
44527 |
0.21 |
chr12_91721216_91721367 | 0.22 |
DCN |
decorin |
144391 |
0.05 |
chr11_64215600_64216212 | 0.22 |
AP003774.4 |
HCG1652096, isoform CRA_a; Uncharacterized protein; cDNA FLJ37045 fis, clone BRACE2012185 |
640 |
0.68 |
chr9_132246124_132246361 | 0.22 |
ENSG00000264298 |
. |
5407 |
0.24 |
chr22_30640971_30641213 | 0.22 |
RP1-102K2.8 |
|
892 |
0.38 |
chr11_65639318_65639911 | 0.22 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
511 |
0.56 |
chr7_90012947_90013805 | 0.22 |
CLDN12 |
claudin 12 |
341 |
0.9 |
chr8_2199973_2200269 | 0.22 |
MYOM2 |
myomesin 2 |
206937 |
0.03 |
chr7_95690232_95690383 | 0.22 |
ENSG00000208025 |
. |
158761 |
0.04 |
chr4_86700210_86700446 | 0.22 |
ARHGAP24 |
Rho GTPase activating protein 24 |
469 |
0.88 |
chr20_23617810_23618640 | 0.22 |
CST3 |
cystatin C |
357 |
0.87 |
chr7_82071524_82071810 | 0.22 |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
1364 |
0.61 |
chr7_116661589_116661740 | 0.21 |
ST7 |
suppression of tumorigenicity 7 |
1333 |
0.44 |
chr5_158438402_158438767 | 0.21 |
CTD-2363C16.2 |
|
25770 |
0.2 |
chr15_52943999_52944218 | 0.21 |
FAM214A |
family with sequence similarity 214, member A |
139 |
0.95 |
chrX_78003533_78003765 | 0.21 |
LPAR4 |
lysophosphatidic acid receptor 4 |
421 |
0.91 |
chr15_77480576_77480727 | 0.21 |
PEAK1 |
pseudopodium-enriched atypical kinase 1 |
64222 |
0.12 |
chr10_77229198_77229525 | 0.21 |
RP11-399K21.10 |
|
38015 |
0.16 |
chr14_63671002_63671585 | 0.21 |
RHOJ |
ras homolog family member J |
167 |
0.97 |
chr19_36207272_36208543 | 0.21 |
KMT2B |
Histone-lysine N-methyltransferase 2B |
1014 |
0.26 |
chr3_152314332_152314547 | 0.21 |
RP11-362A9.3 |
|
99837 |
0.08 |
chr2_121499238_121499672 | 0.21 |
GLI2 |
GLI family zinc finger 2 |
5632 |
0.32 |
chr17_39861478_39861907 | 0.21 |
GAST |
gastrin |
6886 |
0.1 |
chr10_34630198_34630349 | 0.21 |
PARD3 |
par-3 family cell polarity regulator |
31188 |
0.25 |
chr9_94183221_94183836 | 0.21 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
2616 |
0.4 |
chr22_46471692_46472277 | 0.21 |
FLJ27365 |
hsa-mir-4763 |
4208 |
0.11 |
chr3_175244326_175245006 | 0.21 |
ENSG00000201648 |
. |
82601 |
0.1 |
chr2_189839524_189839773 | 0.21 |
COL3A1 |
collagen, type III, alpha 1 |
549 |
0.79 |
chr3_112358713_112358917 | 0.21 |
CCDC80 |
coiled-coil domain containing 80 |
1301 |
0.54 |
chr3_194840398_194840606 | 0.21 |
XXYLT1 |
xyloside xylosyltransferase 1 |
2419 |
0.23 |
chrX_3379202_3379389 | 0.21 |
ENSG00000212214 |
. |
70997 |
0.11 |
chr8_25042452_25043634 | 0.20 |
DOCK5 |
dedicator of cytokinesis 5 |
663 |
0.75 |
chr22_45865037_45865472 | 0.20 |
RP1-102D24.5 |
|
20630 |
0.17 |
chr7_83768499_83768650 | 0.20 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
55643 |
0.18 |
chr6_56706635_56706858 | 0.20 |
DST |
dystonin |
1197 |
0.47 |
chr9_130639317_130639975 | 0.20 |
AK1 |
adenylate kinase 1 |
376 |
0.71 |
chr15_96883311_96883827 | 0.20 |
ENSG00000222651 |
. |
7079 |
0.16 |
chr3_66139685_66140118 | 0.20 |
SLC25A26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
20616 |
0.25 |
chr3_106064913_106065064 | 0.20 |
ENSG00000200610 |
. |
169756 |
0.04 |
chr12_32687758_32688027 | 0.20 |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
634 |
0.8 |
chr2_216299376_216299642 | 0.20 |
FN1 |
fibronectin 1 |
1281 |
0.4 |
chr1_162602563_162603214 | 0.20 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
628 |
0.74 |
chr5_115961898_115962197 | 0.20 |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
51417 |
0.18 |
chr5_151060368_151060611 | 0.20 |
CTB-113P19.1 |
|
3955 |
0.17 |
chr2_189842191_189842342 | 0.20 |
ENSG00000221502 |
. |
552 |
0.78 |
chr11_123059250_123059539 | 0.20 |
CTD-2216M2.1 |
|
116 |
0.97 |
chr8_87718795_87718946 | 0.20 |
RP11-386D6.1 |
|
905 |
0.65 |
chr2_188417302_188417453 | 0.20 |
AC007319.1 |
|
1499 |
0.38 |
chr17_48366854_48367409 | 0.20 |
RP11-893F2.9 |
|
1915 |
0.24 |
chr13_110958781_110959436 | 0.20 |
COL4A1 |
collagen, type IV, alpha 1 |
370 |
0.6 |
chr14_52121858_52122101 | 0.20 |
FRMD6 |
FERM domain containing 6 |
3281 |
0.25 |
chr1_54587067_54587332 | 0.20 |
AL161915.1 |
Uncharacterized protein |
17231 |
0.13 |
chr7_27202641_27202952 | 0.20 |
HOXA9 |
homeobox A9 |
2349 |
0.09 |
chr15_42749089_42749416 | 0.20 |
ZNF106 |
zinc finger protein 106 |
459 |
0.78 |
chr17_19966866_19967068 | 0.20 |
SPECC1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
23367 |
0.18 |
chr8_25946426_25946850 | 0.20 |
EBF2 |
early B-cell factor 2 |
43725 |
0.17 |
chr1_244609044_244609215 | 0.20 |
ADSS |
adenylosuccinate synthase |
6307 |
0.21 |
chr8_108507547_108507698 | 0.20 |
ANGPT1 |
angiopoietin 1 |
399 |
0.92 |
chr10_114714851_114715858 | 0.19 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr9_18976648_18977105 | 0.19 |
FAM154A |
family with sequence similarity 154, member A |
56310 |
0.1 |
chr1_78356045_78356196 | 0.19 |
NEXN-AS1 |
NEXN antisense RNA 1 |
896 |
0.52 |
chr22_46423027_46423794 | 0.19 |
RP6-109B7.5 |
|
25563 |
0.09 |
chr7_94004298_94004620 | 0.19 |
COL1A2 |
collagen, type I, alpha 2 |
19414 |
0.26 |
chr8_117133283_117133521 | 0.19 |
ENSG00000221793 |
. |
15596 |
0.28 |
chrX_103381032_103381192 | 0.19 |
SLC25A53 |
solute carrier family 25, member 53 |
20596 |
0.16 |
chr19_30865612_30866061 | 0.19 |
ZNF536 |
zinc finger protein 536 |
2517 |
0.44 |
chr6_143193241_143193570 | 0.19 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
35221 |
0.21 |
chr2_89180194_89180345 | 0.19 |
IGKV4-1 |
immunoglobulin kappa variable 4-1 |
4644 |
0.09 |
chr12_78336681_78336916 | 0.19 |
NAV3 |
neuron navigator 3 |
23258 |
0.28 |
chr10_62059868_62060258 | 0.19 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
177 |
0.97 |
chr1_68084153_68084510 | 0.19 |
ENSG00000242482 |
. |
38481 |
0.16 |
chr14_85998039_85998552 | 0.19 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
1723 |
0.42 |
chr2_14633353_14633613 | 0.19 |
FAM84A |
family with sequence similarity 84, member A |
139327 |
0.05 |
chr11_8740394_8740932 | 0.19 |
ST5 |
suppression of tumorigenicity 5 |
27 |
0.96 |
chr5_15500636_15500842 | 0.19 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
434 |
0.91 |
chr2_66663002_66663153 | 0.19 |
MEIS1 |
Meis homeobox 1 |
387 |
0.81 |
chr16_53244996_53245358 | 0.19 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
2814 |
0.29 |
chr2_144303459_144303649 | 0.19 |
RP11-570L15.2 |
|
26120 |
0.19 |
chr6_76059036_76059425 | 0.19 |
RP11-415D17.3 |
|
7700 |
0.18 |
chr17_47077080_47077320 | 0.19 |
IGF2BP1 |
insulin-like growth factor 2 mRNA binding protein 1 |
2092 |
0.16 |
chr1_201619186_201619405 | 0.19 |
NAV1 |
neuron navigator 1 |
1845 |
0.29 |
chr12_105627028_105627183 | 0.19 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
123 |
0.97 |
chr13_110954925_110955076 | 0.19 |
COL4A2 |
collagen, type IV, alpha 2 |
3159 |
0.28 |
chr2_188269361_188269539 | 0.19 |
CALCRL |
calcitonin receptor-like |
43529 |
0.19 |
chr12_63254560_63254711 | 0.19 |
ENSG00000200296 |
. |
9954 |
0.25 |
chr9_114671696_114672066 | 0.19 |
UGCG |
UDP-glucose ceramide glucosyltransferase |
12835 |
0.19 |
chrX_106898289_106898771 | 0.19 |
PRPS1 |
phosphoribosyl pyrophosphate synthetase 1 |
15942 |
0.22 |
chr12_69809879_69810030 | 0.19 |
ENSG00000266185 |
. |
15271 |
0.18 |
chr1_172154318_172154604 | 0.18 |
DNM3OS |
DNM3 opposite strand/antisense RNA |
40527 |
0.14 |
chrX_110038687_110039773 | 0.18 |
CHRDL1 |
chordin-like 1 |
56 |
0.99 |
chr8_132929065_132929278 | 0.18 |
EFR3A |
EFR3 homolog A (S. cerevisiae) |
12815 |
0.3 |
chr10_30346002_30346153 | 0.18 |
KIAA1462 |
KIAA1462 |
2376 |
0.44 |
chr15_34531260_34531657 | 0.18 |
EMC4 |
ER membrane protein complex subunit 4 |
11562 |
0.14 |
chr15_93258311_93258462 | 0.18 |
FAM174B |
family with sequence similarity 174, member B |
47113 |
0.14 |
chr3_16217443_16217716 | 0.18 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
1363 |
0.53 |
chr7_158314531_158314682 | 0.18 |
ENSG00000207637 |
. |
10899 |
0.17 |
chr17_42544837_42545068 | 0.18 |
GPATCH8 |
G patch domain containing 8 |
35807 |
0.12 |
chr12_115889459_115889637 | 0.18 |
RP11-116D17.1 |
HCG2038717; Uncharacterized protein |
88731 |
0.1 |
chr13_38171648_38172094 | 0.18 |
POSTN |
periostin, osteoblast specific factor |
992 |
0.71 |
chr2_202901871_202902113 | 0.18 |
FZD7 |
frizzled family receptor 7 |
2682 |
0.25 |
chr20_11871763_11872529 | 0.18 |
BTBD3 |
BTB (POZ) domain containing 3 |
171 |
0.97 |
chrX_49801111_49801262 | 0.18 |
ENSG00000272080 |
. |
21980 |
0.08 |
chr15_92104669_92104931 | 0.18 |
ENSG00000238981 |
. |
273809 |
0.01 |
chr17_40284922_40285123 | 0.18 |
RAB5C |
RAB5C, member RAS oncogene family |
3427 |
0.12 |
chr17_38440207_38440497 | 0.18 |
CDC6 |
cell division cycle 6 |
3533 |
0.16 |
chr4_159093168_159093728 | 0.18 |
RP11-597D13.9 |
|
281 |
0.64 |
chr2_232545912_232546437 | 0.18 |
MGC4771 |
|
25447 |
0.14 |
chr10_113962747_113962898 | 0.18 |
GPAM |
glycerol-3-phosphate acyltransferase, mitochondrial |
19297 |
0.25 |
chr15_61327175_61327382 | 0.18 |
RP11-39M21.1 |
|
146170 |
0.04 |
chr15_37180001_37180243 | 0.18 |
ENSG00000212511 |
. |
35281 |
0.22 |
chr9_20725861_20726160 | 0.18 |
ENSG00000207609 |
. |
9906 |
0.2 |
chr3_114788095_114788246 | 0.18 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
2052 |
0.5 |
chr5_86264086_86264257 | 0.18 |
ENSG00000251951 |
. |
134492 |
0.05 |
chr8_131960988_131961496 | 0.18 |
RP11-737F9.1 |
|
13587 |
0.24 |
chr5_39421621_39421795 | 0.18 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
3262 |
0.35 |
chr4_143273250_143273504 | 0.18 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
46280 |
0.21 |
chr9_113940701_113941000 | 0.18 |
ENSG00000212409 |
. |
81157 |
0.1 |
chr22_17679684_17679946 | 0.18 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
858 |
0.6 |
chrX_129473317_129474471 | 0.18 |
SLC25A14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
7 |
0.98 |
chr8_141248678_141248836 | 0.18 |
TRAPPC9 |
trafficking protein particle complex 9 |
212272 |
0.02 |
chr7_137028027_137028276 | 0.18 |
PTN |
pleiotrophin |
369 |
0.92 |
chr18_52942632_52942783 | 0.18 |
TCF4 |
transcription factor 4 |
195 |
0.97 |
chr1_17866390_17866720 | 0.18 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
225 |
0.95 |
chrX_84499187_84500398 | 0.18 |
ZNF711 |
zinc finger protein 711 |
21 |
0.94 |
chr8_55294582_55295235 | 0.18 |
ENSG00000244107 |
. |
38120 |
0.17 |
chr10_30872530_30872876 | 0.17 |
ENSG00000239744 |
. |
27870 |
0.19 |
chrX_69674453_69675874 | 0.17 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chr13_101527616_101527852 | 0.17 |
NALCN-AS1 |
NALCN antisense RNA 1 |
167155 |
0.04 |
chr11_16023597_16024065 | 0.17 |
CTD-3096P4.1 |
|
20905 |
0.28 |
chr4_26022444_26022665 | 0.17 |
SMIM20 |
small integral membrane protein 20 |
106623 |
0.07 |
chr18_9701912_9702261 | 0.17 |
RAB31 |
RAB31, member RAS oncogene family |
6076 |
0.24 |
chr12_27398836_27399341 | 0.17 |
STK38L |
serine/threonine kinase 38 like |
498 |
0.86 |
chr1_56943161_56943502 | 0.17 |
ENSG00000223307 |
. |
100241 |
0.08 |
chr16_17547681_17547832 | 0.17 |
XYLT1 |
xylosyltransferase I |
16982 |
0.31 |
chr9_14353312_14353885 | 0.17 |
RP11-120J1.1 |
|
6279 |
0.28 |
chr2_225847014_225847203 | 0.17 |
ENSG00000263828 |
. |
28149 |
0.22 |
chr17_60868253_60868692 | 0.17 |
MARCH10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
15529 |
0.23 |
chr4_184264353_184264576 | 0.17 |
ENSG00000238596 |
. |
14013 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0021508 | floor plate formation(GO:0021508) |
0.1 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.2 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0048343 | paraxial mesodermal cell differentiation(GO:0048342) paraxial mesodermal cell fate commitment(GO:0048343) |
0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0003136 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0051284 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.3 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.0 | 0.1 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.0 | GO:0061140 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.0 | GO:0072176 | nephric duct development(GO:0072176) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0031223 | response to auditory stimulus(GO:0010996) auditory behavior(GO:0031223) |
0.0 | 0.0 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.0 | GO:1903312 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.0 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.0 | GO:0060900 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.0 | GO:0072191 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.0 | 0.0 | GO:0036445 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.0 | 0.0 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.0 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.0 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.0 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 1.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |